Table 1.

Surviving CD4⁺/CD8⁺ cells in splenocytes of mice shown in Figs. 6 and 7

Group of mice	a %CD4+ b	% CD8+ b
Control Ig	23 ± 4.1	7.1 ± 2.2
Control C1	6.3 ± 1.5*	2.5 ± 0.6*
Control C2	26 ± 3.8	7.0 ± 2.5
Anti-CD4 treated	6.0 ± 2.1*	10 ± 2.9
Anti-CD8 treated	27 ± 5.5	1.9 ± 0.5*
Anti-CD4+ anti-CD8 treated	6.7 ± 2.8*	2.0 ± 1.2*

^aMice were immunized with OVA; received additional treatment with combined anti-idiotype and immune Ig; and also, anti-CD4 and/or anti-CD8 as indicated in Figs. 6 and 7

^b% positive CD4⁺ and CD8⁺ cells in splenocytes of mice treated as in Fig. 6 and sacrificed 10 days after the last OVA immunization. Data show means (± SD) for groups of 7 mice

* p < 0.05 compared with first row, control Ig group (no anti-idiotype Ig/Immune Ig and no anti-CD4/-CD8)